MedTrace Logo

Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer

NCT01628458 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2015-02-02

No results posted yet for this study

Summary

The purpose of the study is to determine the safety of radiofrequency ablation of locally advanced pancreatic cancer that can not be surgically removed with the current standard procedures. Complications after the operation will be registered. Moreover a pain score will be determined, length of hospital stay, chemotherapy, survival, progression free survival and a tumour marker.

Conditions

Interventions

PROCEDURE

radiofrequency ablation (RFA)

RFA with CELON bipolar probes. Settings: Power 30 watts, total energy 15 KJ.

Sponsors & Collaborators

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Richard van Hillegersberg, Professor · UMC Utrecht

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-07-31
Completion
2014-11-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01628458 on ClinicalTrials.gov